Literature DB >> 17163499

Effects of a distance learning program on physicians' opioid- and benzodiazepine-prescribing skills.

Deana Midmer1, Meldon Kahan, Bernard Marlow.   

Abstract

INTRODUCTION: Opioid misuse is common among patients with chronic nonmalignant pain. There is a pressing need for physicians to increase their confidence and competence in managing these patients.
METHODS: A randomized controlled trial of family physicians (N = 88) attending 1 of 4 continuing medical education events helped to determine the effectiveness of e-mail case discussions in changing physician behavior. Before random assignment, participants completed a pretest and attended a 3-hour didactic session on prescribing opioids and benzodiazepines. The intervention group participated in 10 weeks of e-mail case discussions, with designated participants responding to questions on cases. An addictions physician facilitated the discussion. Several months after the e-mail discussion, participants took part in a mock telephone consultation; a blinded researcher posing as a medical colleague asked for advice about 2 cases involving opioid and benzodiazepine prescribing. Using a checklist, the researcher recorded the questions asked and advice given by the physician.
RESULTS: On post-testing, both groups expressed greater optimism about treatment outcomes and were more likely to report using a treatment contract and providing advice about sleep hygiene. There were no significant differences between pretesting and post-testing between the groups on the survey. During the telephone consultation, the intervention group asked significantly more questions and offered more advice than the control group (odds ratio for question items, 1.27 [p = .03]; advice items, 1.33 [p = .01). DISCUSSION: Facilitated by electronic mail and a medical expert, case discussion is an effective means of improving physician performance. Telephone consultation holds promise as a method for evaluating physicians' assessment and management skills.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17163499     DOI: 10.1002/chp.82

Source DB:  PubMed          Journal:  J Contin Educ Health Prof        ISSN: 0894-1912            Impact factor:   1.355


  7 in total

Review 1.  GPs and problem gambling: can they help with identification and early intervention?

Authors:  Barry Tolchard; Lyndall Thomas; Malcolm Battersby
Journal:  J Gambl Stud       Date:  2007-04-24

2.  Opioid prescribing habits of physicians in Kwara State, Nigeria.

Authors:  Zakari A Suleiman; Kolawole W Wahab; Israel K Kolawole
Journal:  Ghana Med J       Date:  2016-06

3.  Survey of Ontario primary care physicians' experiences with opioid prescribing.

Authors:  Elizabeth Francis Wenghofer; Lynn Wilson; Meldon Kahan; Carolynn Sheehan; Anita Srivastava; Ava Rubin; Joanne Brathwaite
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

4.  Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing.

Authors:  Meldon Kahan; Tara Gomes; David N Juurlink; Michael Manno; Lynn Wilson; Angela Mailis-Gagnon; Anita Srivastava; Rhoda Reardon; Irfan A Dhalla; Muhammad M Mamdani
Journal:  Can Fam Physician       Date:  2013-05       Impact factor: 3.275

5.  Online Digital Education for Postregistration Training of Medical Doctors: Systematic Review by the Digital Health Education Collaboration.

Authors:  Pradeep Paul George; Olena Zhabenko; Bhone Myint Kyaw; Panagiotis Antoniou; Pawel Posadzki; Nakul Saxena; Monika Semwal; Lorainne Tudor Car; Nabil Zary; Craig Lockwood; Josip Car
Journal:  J Med Internet Res       Date:  2019-02-25       Impact factor: 5.428

6.  Digital Learning to Improve Safe and Effective Prescribing: A Systematic Review.

Authors:  Michiel J Bakkum; Jelle Tichelaar; Anne Wellink; Milan C Richir; Michiel A van Agtmael
Journal:  Clin Pharmacol Ther       Date:  2019-07-29       Impact factor: 6.875

Review 7.  Evaluations of Continuing Health Provider Education Focused on Opioid Prescribing: A Scoping Review.

Authors:  Abhimanyu Sud; Graziella R Molska; Fabio Salamanca-Buentello
Journal:  Acad Med       Date:  2022-02-01       Impact factor: 7.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.